AGENDA

ANTIBODY-DRUG CONJUGATES IN OVARIAN CANCER 

TARGETING DNA REPAIR IN OVARIAN CANCER 

REPLICATION STRESS, CELL CYCLE CHECKPOINTS, AND RESTORING THE TP53 PATHWAY IN OVARIAN AND ENDOMETRIAL CANCER

IMMUNE-CHECKPOINT BLOCKADE AND IMMUNE MODULATION IN GYNECOLOGIC MALIGNANCIES 

PATHWAY-DIRECTED AND HORMONE-RECEPTOR THERAPY IN GYNECOLOGIC MALIGNANCIES 

ANTIBODY-DRUG CONJUGATES IN ENDOMETRIAL AND CERVICAL CANCER 

HER2-DIRECTED THERAPY